Regenexx is a world leader in the field of orthopaedic restorative medicine based on scientific publications and is arguably the world’s most advanced platform for in-office interventional orthopaedics.
159,650
More than 159,650 highly specific image-guided Regenexx procedures have been performed since Regenexx pioneered the field of Interventional Orthopaedics, using bone marrow concentrate to treat common orthopaedic problems in 2005.
44%
The published research on Regenexx procedures accounts for approximately 44% of the world’s research on the use of bone marrow concentrate for orthopaedic conditions (cumulative number of patients published & treated with bone marrow concentrate as of 1/1/2019)
